MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen.

Tengström, Maria

MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen. [electronic resource] - Acta oncologica (Stockholm, Sweden) Jun 2014 - 769-75 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1651-226X

10.3109/0284186X.2014.892210 doi


Adult
Aged
Antineoplastic Agents, Hormonal--therapeutic use
Breast Neoplasms--drug therapy
Carcinoma--drug therapy
Case-Control Studies
Chemotherapy, Adjuvant
Cohort Studies
Disease-Free Survival
Female
Genotype
Humans
Kaplan-Meier Estimate
Middle Aged
Polymorphism, Single Nucleotide
Prognosis
Proportional Hazards Models
Prospective Studies
Superoxide Dismutase--genetics
Tamoxifen--therapeutic use
Xeroderma Pigmentosum Group D Protein--genetics